Holen Sie sich die Stockscreener-App
88.95
0.33%
0.29
Handel nachbörslich:
88.95
Schlusskurs vom Vortag:
$88.66
Offen:
$88
24-Stunden-Volumen:
14.25M
Relative Volume:
2.59
Marktkapitalisierung:
$131.10B
Einnahmen:
$15.91B
Nettoeinkommen (Verlust:
$1.79B
KGV:
108.48
EPS:
0.82
Netto-Cashflow:
$1.89B
1W Leistung:
-1.29%
1M Leistung:
-1.35%
6M Leistung:
+15.52%
1J Leistung:
+61.79%
1-Tages-Spanne:
$87.25
$89.67
1-Wochen-Bereich:
$87.25
$91.59
52-Wochen-Spanne:
$54.95
$91.93
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch
Truist maintains Buy on Boston Scientific with $110 target - Investing.com
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries - Benzinga
Should You Be Adding Boston Scientific (NYSE:BSX) To Your Watchlist Today? - Yahoo Finance
Principal Financial Group Inc. Buys 111,724 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pain Management Devices Market May See a Big Move | Medtronic, Boston Scientific, LivaNova - openPR
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy - Yahoo Finance
Boston Scientific updates instructions for cryoablation catheters after reported deaths - Mass Device
Boston Scientific price target raised to $110 from $100 at Truist - Yahoo Finance
Boston Scientific updates cryoablation catheter instructions after 4 death reports - Yahoo Finance
FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters.com
FDA classifies recall of Boston Scientific catheters as 'most serious' By Reuters - Investing.com
Boston Scientific shares target increased, holds Buy on growth prospects - Investing.com
Boston Scientific (NYSE:BSX) Price Target Raised to $110.00 - MarketBeat
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific recalls Accolade pacemakers tied to 2 deaths - Yahoo Finance
Boston Scientific warns on potential need to replace Accolade pacemaker devices early - Mass Device
Boston Scientific has a new Peripheral Interventions leader in EMEA - Mass Device
Sanctuary Advisors LLC Sells 6,069 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Wilmington Savings Fund Society FSB Makes New Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 121% gain - Yahoo Finance
Short Interest in Boston Scientific Co. (NYSE:BSX) Grows By 11.2% - MarketBeat
Jim Cramer on Boston Scientific Corporation (BSX): ‘A Superior Company’ - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
Oddo BHF Asset Management Sas Buys New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Franklin Resources Inc. - MarketBeat
Boston Scientific best idea at TD Cowen, lifts PT by $10 - Investing.com
Boston Scientific shares target lifted, buy rating on robust performance - Investing.com
Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes - Yahoo Finance
Boston Scientific Co. (NYSE:BSX) Shares Sold by Toronto Dominion Bank - MarketBeat
Teachers Retirement System of The State of Kentucky Sells 150,603 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
TCW Group Inc. Sells 147,999 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace - Quantisnow
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace – Company Announcement - Financial Times
Brown Financial Advisors Has $1.04 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Vestcor Inc Has $3.38 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific Corporation (NYSE:BSX) Could Be Worth Watching - Yahoo Finance
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) Stock Holdings Decreased by Nomura Asset Management Co. Ltd. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Position Increased by Zacks Investment Management - MarketBeat
National Bank of Canada FI Increases Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
United Services Automobile Association Sells 7,295 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Worldquant Millennium Advisors LLC Makes New $9.04 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Canada Finance
Layoffs in medtech: These companies recently reduced their workforce - Mass Device
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):